CRIS Current Research Information System

LAURIOLA, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.834
EU - Europa 3.666
AS - Asia 3.462
AF - Africa 239
SA - Sud America 230
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.450
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.785
IT - Italia 1.537
SG - Singapore 1.204
CN - Cina 1.140
GB - Regno Unito 482
DE - Germania 400
VN - Vietnam 332
SE - Svezia 296
HK - Hong Kong 273
BR - Brasile 178
IN - India 148
KR - Corea 141
IE - Irlanda 138
NL - Olanda 137
FR - Francia 118
RU - Federazione Russa 116
AT - Austria 108
CI - Costa d'Avorio 89
FI - Finlandia 74
TG - Togo 56
ZA - Sudafrica 54
UA - Ucraina 52
JO - Giordania 43
JP - Giappone 42
BG - Bulgaria 40
EE - Estonia 40
ID - Indonesia 39
CA - Canada 34
CH - Svizzera 33
AR - Argentina 26
SC - Seychelles 22
ES - Italia 20
PL - Polonia 17
AU - Australia 16
IL - Israele 16
IR - Iran 14
MY - Malesia 14
GR - Grecia 12
DK - Danimarca 11
BD - Bangladesh 10
TR - Turchia 9
EC - Ecuador 8
MX - Messico 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
BE - Belgio 6
PK - Pakistan 6
RO - Romania 6
CO - Colombia 5
NG - Nigeria 5
PY - Paraguay 5
HR - Croazia 4
TH - Thailandia 4
TW - Taiwan 4
UZ - Uzbekistan 4
CR - Costa Rica 3
KE - Kenya 3
MA - Marocco 3
PE - Perù 3
PT - Portogallo 3
CM - Camerun 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
LB - Libano 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CL - Cile 1
CU - Cuba 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
IQ - Iraq 1
JE - Jersey 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 11.450
Salva come PNG Salva come JPEG
Città #
Singapore 808
Bologna 662
Ashburn 501
Southend 415
Chandler 354
Fairfield 324
Hefei 321
Hong Kong 261
Houston 235
Seattle 177
Santa Clara 162
Woodbridge 162
Dublin 135
Seoul 135
Wilmington 135
Cambridge 121
Princeton 117
Beijing 112
Milan 105
Boardman 103
Dallas 97
Vienna 97
Abidjan 89
Dong Ket 79
Ann Arbor 74
Ho Chi Minh City 66
Hanoi 65
Redmond 61
Bremen 58
Los Angeles 58
Lomé 56
Nanjing 55
Westminster 46
Amman 43
Berlin 43
Helsinki 43
New York 40
Sofia 40
Munich 39
Rome 39
Tokyo 38
São Paulo 37
Padova 34
Modena 33
Bengaluru 31
Jakarta 31
Shanghai 29
Buffalo 28
Amsterdam 26
Bern 25
Frankfurt am Main 25
Jinan 25
Nuremberg 25
Saint Petersburg 25
London 24
Redondo Beach 24
Guangzhou 23
Shenyang 22
Turin 22
Florence 21
Naples 21
Medford 20
San Diego 18
Chicago 16
Jacksonville 16
Jiaxing 16
Lappeenranta 16
Reggio Emilia 16
Boydton 15
Falkenstein 15
Turku 15
San Francisco 14
Zhengzhou 14
Düsseldorf 13
Forlì 13
Olalla 13
Orem 13
Rehovot 13
Brescia 12
Changsha 12
Montreal 12
Toronto 12
Falls Church 11
Phoenix 11
Tianjin 11
Dearborn 10
Haikou 10
Redwood City 10
Warsaw 10
Wuhan 10
Casalecchio Di Reno 9
Nanchang 9
Stockholm 9
Xi'an 9
Council Bluffs 8
Crevalcore 8
Ferrara 8
Kuala Lumpur 8
Norwalk 8
Thái Nguyên 8
Totale 7.573
Salva come PNG Salva come JPEG
Nome #
Glucocorticoid receptor antagonization propels endogenous cardiomyocyte proliferation and cardiac regeneration 324
BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice 254
EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer 243
Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects 223
Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer 218
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 215
Human trisomy 21 fibroblasts rescue methotrexate toxic effect after treatment with 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate 208
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression 200
IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. 198
A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onset. 194
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy 188
Submicroscopic alterations and gene expression profiles of human colon cancer cell lines in response to cetuximab, gefitinib and EGF 185
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy 183
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib 179
Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection 177
Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines. 175
Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood 174
The EGFR R521K polymorphism influences the risk to develop colorectal cancer. 173
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 173
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation 172
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 171
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 169
Modulation of ERBB signaling from tissue homeostasis to cancer progression 169
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 168
CEA Cell Adhesion Molecule 6 (CEACAM6), Collagen Type I Alpha 2 Chain (COL1A2), Galectin 4 (LGALS4) and Tetraspanin 8 (TSPAN8) mRNAs as blood biomarkers for colorectal cancer 168
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization 167
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies 166
Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer. 163
Gene expression profile of human colon cancer cells treated with cross-reacting material 197, a diphtheria toxin non-toxic mutant. 161
Mechanisms of acquired resistance to cetuximab: role of interleukin 1 161
The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms. 160
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies 158
The roadmap of colorectal cancer screening 153
ERBB2 circumvents negative feedback mechanisms induced by EGFR overactivation in basal-like/triple-negative breast cancer cells 149
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems 149
Estrogen Receptors and Melanoma: A Review 148
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 147
Resistance to EGFR Targeting Treatments in Colorectal Cancer 147
A putative role for interleukin 1 pathway in resistance to EGFR blockade 144
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer 141
ERBB RECEPTORS DIMERIZATION DEFINES BREAST CANCERS SUBTYPES AND CLINICAL OUTCOMES: IMPLICATION FOR CANCER THERAPIES 140
Fibroblast-associated protein-α expression and BPV nucleic acid distribution in equine sarcoids 138
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection 137
null 136
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor 134
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors 134
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling 133
The R521K polymorphism of EGFR influences the risk of colorectal cancer 131
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells 130
null 128
qCMA: A Desktop Application for Quantitative Collective Cell Migration Analysis 123
null 121
A novel role for interleukin 1 axis in the resistance to EGFR targeting antibody 121
null 117
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 114
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in Consensus Molecular Subtype 1 colon cancer 113
Identification of novel growth factors for cardiac regeneration 112
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 109
Female melanoma and estrogen receptors expression: an immunohistochemical pilot study 108
Unveiling the role of interleukine-1 Receptor in response to EGFR blockade 106
Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways 104
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions 102
Modeling ductal carcinoma in situ: a HER2–Notch3 collaboration enables luminal filling 99
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors 98
Beta-Catenin/HuR Post-Transcriptional Machinery Governs Cancer Stem Cell Features in Response to Hypoxia 98
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 97
Two Phases of Mitogenic Signaling Unveil Roles for p53 and EGR1 in Elimination of Inconsistent Growth Signals 97
A new method for the study of biophysical and morphological parameters in 3D cell cultures: Evaluation in LoVo spheroids treated with crizotinib 97
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 95
null 87
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors 84
null 82
null 81
Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment. 79
Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies 75
null 74
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result 73
null 72
ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation 72
Targeting anaplastic lymphoma kinase in consensus molecular subtype 1 colon cancer patients 69
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 67
Diagnostic Accuracy of an Add-On, Blood-Based Screening Test for Colorectal Cancer in Two Established Screening Programmes 50
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer 46
Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression 39
CIRCADIAN DEPENDENT MOTILITY: THE ROLE FOR THE PERINUCLEAR ACTIN CAP 35
Developing Comprehensive In Vitro and In Vivo Models: Patient-Derived Organoids (PDOs) and Xenografts (PDXs) for Morphological and Functional Analysis and Drug Screening in Head and Neck Squamous Cell Carcinoma 27
Development of Head and Neck Squamous Cell Carcinoma Patient-Derived Xenografts (PDXs) and Organoids (PDXOs) for Morphological Analysis and Drug Screening 26
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 22
Towards the emerging crosstalk: ERBB family and steroid hormones 22
Circadian dependent motility: the role for the perinuclear actin cap 17
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 12
Totale 11.798
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.815
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021453 0 0 0 0 0 0 24 60 60 37 61 211
2021/20221.144 71 38 60 57 88 64 32 81 74 81 250 248
2022/20231.788 142 220 101 253 147 135 79 130 306 49 105 121
2023/2024752 59 93 40 75 60 144 40 46 25 75 41 54
2024/20252.582 104 235 225 181 281 147 295 143 85 209 235 442
2025/20262.929 469 584 526 428 516 367 39 0 0 0 0 0
Totale 11.798